Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Abstract

Traumatic brain injury (TBI) is a complex disease in the most complex organ of the body, whose victims endure lifelong debilitating physical, emotional, and psychosocial consequences. Despite advances in clinical care, there is no effective neuroprotective therapy for TBI, with almost every compound showing promise experimentally having disappointing results in the clinic. The complex and highly interrelated innate immune responses govern both the beneficial and deleterious molecular consequences of TBI and are present as an attractive therapeutic target. This paper discusses the positive, negative, and often conflicting roles of the innate immune response to TBI in both an experimental and clinical settings and highlights recent advances in the search for therapeutic candidates for the treatment of TBI.
Original languageEnglish
Pages (from-to)1 - 18
Number of pages18
JournalMediators of Inflammation
Volume2012
Issue numberArt. ID: 356494
DOIs
Publication statusPublished - 2012

Cite this

@article{2d854a261b41441d99c035278bdd956d,
title = "Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury",
abstract = "Traumatic brain injury (TBI) is a complex disease in the most complex organ of the body, whose victims endure lifelong debilitating physical, emotional, and psychosocial consequences. Despite advances in clinical care, there is no effective neuroprotective therapy for TBI, with almost every compound showing promise experimentally having disappointing results in the clinic. The complex and highly interrelated innate immune responses govern both the beneficial and deleterious molecular consequences of TBI and are present as an attractive therapeutic target. This paper discusses the positive, negative, and often conflicting roles of the innate immune response to TBI in both an experimental and clinical settings and highlights recent advances in the search for therapeutic candidates for the treatment of TBI.",
author = "Sarah Hellewell and Morganti-Kossmann, {Maria Cristina}",
year = "2012",
doi = "10.1155/2012/356494",
language = "English",
volume = "2012",
pages = "1 -- 18",
journal = "Mediators of Inflammation",
issn = "0962-9351",
publisher = "Hindawi Publishing Corporation",
number = "Art. ID: 356494",

}

Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury. / Hellewell, Sarah; Morganti-Kossmann, Maria Cristina.

In: Mediators of Inflammation, Vol. 2012, No. Art. ID: 356494, 2012, p. 1 - 18.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury

AU - Hellewell, Sarah

AU - Morganti-Kossmann, Maria Cristina

PY - 2012

Y1 - 2012

N2 - Traumatic brain injury (TBI) is a complex disease in the most complex organ of the body, whose victims endure lifelong debilitating physical, emotional, and psychosocial consequences. Despite advances in clinical care, there is no effective neuroprotective therapy for TBI, with almost every compound showing promise experimentally having disappointing results in the clinic. The complex and highly interrelated innate immune responses govern both the beneficial and deleterious molecular consequences of TBI and are present as an attractive therapeutic target. This paper discusses the positive, negative, and often conflicting roles of the innate immune response to TBI in both an experimental and clinical settings and highlights recent advances in the search for therapeutic candidates for the treatment of TBI.

AB - Traumatic brain injury (TBI) is a complex disease in the most complex organ of the body, whose victims endure lifelong debilitating physical, emotional, and psychosocial consequences. Despite advances in clinical care, there is no effective neuroprotective therapy for TBI, with almost every compound showing promise experimentally having disappointing results in the clinic. The complex and highly interrelated innate immune responses govern both the beneficial and deleterious molecular consequences of TBI and are present as an attractive therapeutic target. This paper discusses the positive, negative, and often conflicting roles of the innate immune response to TBI in both an experimental and clinical settings and highlights recent advances in the search for therapeutic candidates for the treatment of TBI.

UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373171/

U2 - 10.1155/2012/356494

DO - 10.1155/2012/356494

M3 - Article

VL - 2012

SP - 1

EP - 18

JO - Mediators of Inflammation

JF - Mediators of Inflammation

SN - 0962-9351

IS - Art. ID: 356494

ER -